Oxbryta (voxelotor) for the Treatment of Sickle Cell Disease
Oxbryta™ (voxelotor) is available in 500mg tablet form for oral administration. Credit: Global Blood Therapeutics, Inc.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more